Skip to main content
Top
Published in: BMC Public Health 1/2017

Open Access 01-12-2017 | Research article

Development and psychometric properties of a questionnaire to measure drug users’ attitudes toward methadone maintenance treatment (DUAMMT) in Iran

Authors: Maryam Khazaee-Pool, Zohreh Arefi, Daem Roshani, Tahereh Pashaei, Koen Ponnet

Published in: BMC Public Health | Issue 1/2017

Login to get access

Abstract

Background

Assessing drug users’ attitudes towards different kinds of addiction treatment is necessary to design tailored strategies. The aim of the present study is to develop and examine the psychometric properties of a new scale, called the DUAMMT, for assessing drug users’ attitudes toward methadone maintenance treatment in Iran.

Methods

A multi-phase development method was applied in developing an instrument from February to December 2016. The item generation and scale development were performed through literature review, a qualitative approach, and interviews with an expert panel. Then, the psychometric properties of the scale were evaluated by means of cross-sectional studies with drug users. We performed an exploratory factor analysis, a confirmatory factor analysis, and item-scale correlations; and we tested the internal consistency of the scale. Furthermore, test-retest reliability was evaluated among an Iranian sample of drug users.

Results

The mean age of participants was 34.12 years. The exploratory factor analysis revealed four factors (perceived barriers, perceived concerns, methadone side effects, and perceived positive effects) containing 17 items that jointly accounted for 60.53% of the observed variance. The confirmatory factor analysis showed a model with appropriate fitness for the data. The Cronbach’s alpha coefficient for the subscales ranged from .70 to .79. The intra-class correlation coefficient (ICC) ranged from .774 to .970, which is well above the acceptable threshold.

Conclusions

The findings of the present study suggest that the DUAMMT is a valid and reliable instrument to measure drug users’ attitudes toward methadone maintenance treatment. The DUAMMT can be applied at the start of treatment so that clinical intervention can be targeted to promote retention in treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Organization, W.H., International statistical classification of diseases and related health problems. 2009. Organization, W.H., International statistical classification of diseases and related health problems. 2009.
2.
go back to reference Huang B, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on alcohol and related conditions.[CME]. J Clin Psychiatry. 2006;67(7):1062–73.CrossRefPubMed Huang B, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on alcohol and related conditions.[CME]. J Clin Psychiatry. 2006;67(7):1062–73.CrossRefPubMed
3.
go back to reference Mathers BM, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014–28.CrossRefPubMed Mathers BM, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014–28.CrossRefPubMed
4.
go back to reference Zaller ND, et al. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 2009;6(2):787–97.CrossRefPubMedPubMedCentral Zaller ND, et al. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 2009;6(2):787–97.CrossRefPubMedPubMedCentral
5.
go back to reference Bobrova N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82:S57–63.CrossRefPubMed Bobrova N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82:S57–63.CrossRefPubMed
6.
go back to reference Altice FL, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentral Altice FL, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentral
7.
go back to reference Naghavi M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–71.CrossRef Naghavi M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–71.CrossRef
8.
go back to reference Degenhardt L, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382(9904):1564–74.CrossRefPubMed Degenhardt L, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382(9904):1564–74.CrossRefPubMed
9.
go back to reference Becker WC, et al. Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1):38–47.CrossRefPubMed Becker WC, et al. Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1):38–47.CrossRefPubMed
10.
go back to reference Conway KP, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2006;67(2):247–58.CrossRefPubMed Conway KP, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2006;67(2):247–58.CrossRefPubMed
11.
go back to reference Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. 1st ed. New York: Springer Science & Business Media; 1991. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. 1st ed. New York: Springer Science & Business Media; 1991.
12.
go back to reference Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209.
13.
go back to reference Amato L, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat. 2005;28(4):321–9.CrossRef Amato L, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat. 2005;28(4):321–9.CrossRef
14.
go back to reference Vijay A, et al. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29–36.CrossRef Vijay A, et al. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29–36.CrossRef
15.
go back to reference Cartwright WS. Economic costs of drug abuse: financial, cost of illness, and services. J Subst Abus Treat. 2008;34(2):224–33.CrossRef Cartwright WS. Economic costs of drug abuse: financial, cost of illness, and services. J Subst Abus Treat. 2008;34(2):224–33.CrossRef
16.
go back to reference Xu H, et al. Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China. Addict Behav. 2012;37(5):657–62.CrossRefPubMed Xu H, et al. Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China. Addict Behav. 2012;37(5):657–62.CrossRefPubMed
17.
go back to reference Lin C, Wu Z, Detels R. Opiate users’ perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Subst Use Misuse. 2011;46(9):1190–8.CrossRefPubMedPubMedCentral Lin C, Wu Z, Detels R. Opiate users’ perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Subst Use Misuse. 2011;46(9):1190–8.CrossRefPubMedPubMedCentral
18.
go back to reference Connock, M., et al., Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. 2007. Connock, M., et al., Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. 2007.
19.
go back to reference Gottheil E, Sterling RC, Weinstein SP. Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis. 1993;12(4):45–57.CrossRefPubMed Gottheil E, Sterling RC, Weinstein SP. Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis. 1993;12(4):45–57.CrossRefPubMed
21.
go back to reference Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93(4):515–32.CrossRefPubMed Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93(4):515–32.CrossRefPubMed
22.
go back to reference Sheerin I, et al. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N Z Med J. 2004;117(1190):492-501. Sheerin I, et al. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N Z Med J. 2004;117(1190):492-501.
24.
go back to reference Al-Tayyib AA, Koester S. Injection drug users’ experience with and attitudes toward methadone clinics in Denver, CO. J Subst Abus Treat. 2011;41(1):30–6.CrossRef Al-Tayyib AA, Koester S. Injection drug users’ experience with and attitudes toward methadone clinics in Denver, CO. J Subst Abus Treat. 2011;41(1):30–6.CrossRef
25.
go back to reference Peterson JA, et al. Why don’t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy. 2010;21(1):36–42.CrossRefPubMed Peterson JA, et al. Why don’t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy. 2010;21(1):36–42.CrossRefPubMed
26.
go back to reference Hunt DE, et al. “It takes your heart”: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20(11–12):1751–71.CrossRefPubMed Hunt DE, et al. “It takes your heart”: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20(11–12):1751–71.CrossRefPubMed
27.
go back to reference Sarasvita R, et al. Predictive factors for treatment retention in methadone programs in Indonesia. J Subst Abus Treat. 2012;42(3):239–46.CrossRef Sarasvita R, et al. Predictive factors for treatment retention in methadone programs in Indonesia. J Subst Abus Treat. 2012;42(3):239–46.CrossRef
28.
go back to reference Razzaghi, E., et al., Rapid situation assessment of drug abuse in Iran, Tehran 2001. UNDCP and Welfare Organization.[cited 2010 Feb 11]. Available from: URL. Razzaghi, E., et al., Rapid situation assessment of drug abuse in Iran, Tehran 2001. UNDCP and Welfare Organization.[cited 2010 Feb 11]. Available from: URL.
29.
go back to reference United Nations Office on Drugs and Crime: World Drug Report 2005. United Nations Office on Drugs and Crime: World Drug Report 2005.
30.
go back to reference Dehghani R, Amiri M. Addiction: a big challenge of social security in Iran. Int J Epidemiol Res. 2016;3(3):201–3. Dehghani R, Amiri M. Addiction: a big challenge of social security in Iran. Int J Epidemiol Res. 2016;3(3):201–3.
31.
go back to reference Pashaei T, et al. Effectiveness of relapse prevention cognitive-behavioral model in opioid-dependent patients participating in the methadone maintenance treatment in Iran. Iran J Public Health. 2013;42(8):896.PubMedPubMedCentral Pashaei T, et al. Effectiveness of relapse prevention cognitive-behavioral model in opioid-dependent patients participating in the methadone maintenance treatment in Iran. Iran J Public Health. 2013;42(8):896.PubMedPubMedCentral
32.
go back to reference World Drug Report. United Nations Office on Drugs and Crime. UNODC. New York; 2011. World Drug Report. United Nations Office on Drugs and Crime. UNODC. New York; 2011.
33.
go back to reference Pashaei T, et al. Assessing the validity and reliability of the Farsi version of inventory drug-taking situations. Iran J Psychiatry. 2013;8(2):80.PubMedPubMedCentral Pashaei T, et al. Assessing the validity and reliability of the Farsi version of inventory drug-taking situations. Iran J Psychiatry. 2013;8(2):80.PubMedPubMedCentral
34.
go back to reference Khazaee-Pool M, et al. Psychometric properties of the Persian version of the time to relapse questionnaire (TRQ) in substance use disorder. Am J Drug Alcohol Abuse. 2016;42(6):682–8.CrossRefPubMed Khazaee-Pool M, et al. Psychometric properties of the Persian version of the time to relapse questionnaire (TRQ) in substance use disorder. Am J Drug Alcohol Abuse. 2016;42(6):682–8.CrossRefPubMed
35.
go back to reference Khazaee-Pool M, Pashaei T, Koen P, Jafari F, Alizadeh R. Decisional Balance Inventory (DBI) Adolescent Form for Smoking: Psychometric Properties of the Persian Version. BMC Public Health. 2017;17(1):507. Khazaee-Pool M, Pashaei T, Koen P, Jafari F, Alizadeh R. Decisional Balance Inventory (DBI) Adolescent Form for Smoking: Psychometric Properties of the Persian Version. BMC Public Health. 2017;17(1):507.
36.
go back to reference Tavakoli Ghouchani H, et al. Factors related to addiction treatment motivations; validity and reliability of an instrument. J Res Health Sci. 2016;16(3):147–52.PubMed Tavakoli Ghouchani H, et al. Factors related to addiction treatment motivations; validity and reliability of an instrument. J Res Health Sci. 2016;16(3):147–52.PubMed
37.
38.
go back to reference Lincoln YS, Guba EG. Naturalistic inquiry. Newbury Park, CA: Sage; 1985. Lincoln YS, Guba EG. Naturalistic inquiry. Newbury Park, CA: Sage; 1985.
39.
40.
go back to reference Waltz CF, Bausell BR. Nursing research: design statistics and computer analysis. 1st ed. Philadelphia: F.A. Davis; 1981. Waltz CF, Bausell BR. Nursing research: design statistics and computer analysis. 1st ed. Philadelphia: F.A. Davis; 1981.
41.
go back to reference Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. 4rd ed. Springer Publishing Company; 2010. Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. 4rd ed. Springer Publishing Company; 2010.
42.
go back to reference Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–97.CrossRefPubMed Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–97.CrossRefPubMed
43.
go back to reference Lawshe CH. A quantitative approach to content validity1. Pers Psychol. 1975;28(4):563–75.CrossRef Lawshe CH. A quantitative approach to content validity1. Pers Psychol. 1975;28(4):563–75.CrossRef
44.
go back to reference Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J. 2002;19(3):499–503.CrossRefPubMed Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J. 2002;19(3):499–503.CrossRefPubMed
45.
go back to reference Gable RK, Wolf MB. Instrument development in the affective domain. 2nd ed. Boston: Kluwer Academic Publishers; 1993. Gable RK, Wolf MB. Instrument development in the affective domain. 2nd ed. Boston: Kluwer Academic Publishers; 1993.
46.
go back to reference Ferguson E, Cox T. Exploratory factor analysis: a users’ guide. Int J Sel Assess. 1993;1(2):84–94.CrossRef Ferguson E, Cox T. Exploratory factor analysis: a users’ guide. Int J Sel Assess. 1993;1(2):84–94.CrossRef
47.
go back to reference Fabrigar LR, et al. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999;4(3):272.CrossRef Fabrigar LR, et al. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999;4(3):272.CrossRef
48.
go back to reference MacCallum RC, et al. Sample size in factor analysis. Psychol Methods. 1999;4(1):84.CrossRef MacCallum RC, et al. Sample size in factor analysis. Psychol Methods. 1999;4(1):84.CrossRef
49.
go back to reference Khazaee-Pool M, et al. Development and psychometric testing of a new instrument to measure factors influencing women’s breast cancer prevention behaviors (ASSISTS). BMC Womens Health. 2016;16(1):1. Khazaee-Pool M, et al. Development and psychometric testing of a new instrument to measure factors influencing women’s breast cancer prevention behaviors (ASSISTS). BMC Womens Health. 2016;16(1):1.
50.
go back to reference Mueller RO. Basic principles of structural equation modeling: An introduction to LISREL and EQS. 1st Ed. New York: Springer; 1999. Mueller RO. Basic principles of structural equation modeling: An introduction to LISREL and EQS. 1st Ed. New York: Springer; 1999.
51.
go back to reference Munro BH. Statistical methods for health care research. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. Munro BH. Statistical methods for health care research. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
52.
go back to reference Kline, R.B., Principles and practice of structural equation modeling, (methodology in the Social Science). 2004. Kline, R.B., Principles and practice of structural equation modeling, (methodology in the Social Science). 2004.
53.
go back to reference Schumacker RE, Lomax RG. A beginner's guide to structural equation modeling. 3rd ed. Psychology Press; 2004. Schumacker RE, Lomax RG. A beginner's guide to structural equation modeling. 3rd ed. Psychology Press; 2004.
54.
go back to reference Bernstein I. Psychometric theory (3rd.). New York, NY, US: McGraw Hill; 1994. Bernstein I. Psychometric theory (3rd.). New York, NY, US: McGraw Hill; 1994.
55.
56.
go back to reference SPSS S. 16.0 for windows. Chicago: SPSS Inc; 2008. SPSS S. 16.0 for windows. Chicago: SPSS Inc; 2008.
57.
go back to reference Jöreskog, K. and D. Sörbom, LISREL 8.80 for Windows [software]. Lincolnwood (IL): Scientific Software International. 2006, Inc. Jöreskog, K. and D. Sörbom, LISREL 8.80 for Windows [software]. Lincolnwood (IL): Scientific Software International. 2006, Inc.
58.
go back to reference Brown BS, Benn GJ, Jansen DR. Methdone maintence: some client opinions. Am J Psychiatry. 1975;132(6):623-26. Brown BS, Benn GJ, Jansen DR. Methdone maintence: some client opinions. Am J Psychiatry. 1975;132(6):623-26.
59.
go back to reference Kayman DJ, et al. Predicting treatment retention with a brief “opinions about methadone” scale. J Psychoactive Drugs. 2006;38(1):93–100.CrossRefPubMed Kayman DJ, et al. Predicting treatment retention with a brief “opinions about methadone” scale. J Psychoactive Drugs. 2006;38(1):93–100.CrossRefPubMed
60.
go back to reference Caplehorn JR, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse. 1997;32(4):399–413.CrossRefPubMed Caplehorn JR, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse. 1997;32(4):399–413.CrossRefPubMed
Metadata
Title
Development and psychometric properties of a questionnaire to measure drug users’ attitudes toward methadone maintenance treatment (DUAMMT) in Iran
Authors
Maryam Khazaee-Pool
Zohreh Arefi
Daem Roshani
Tahereh Pashaei
Koen Ponnet
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4911-6

Other articles of this Issue 1/2017

BMC Public Health 1/2017 Go to the issue